Karl L. Womer

2.2k total citations
55 papers, 1.6k citations indexed

About

Karl L. Womer is a scholar working on Surgery, Transplantation and Immunology. According to data from OpenAlex, Karl L. Womer has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 22 papers in Transplantation and 19 papers in Immunology. Recurrent topics in Karl L. Womer's work include Renal Transplantation Outcomes and Treatments (20 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Polyomavirus and related diseases (11 papers). Karl L. Womer is often cited by papers focused on Renal Transplantation Outcomes and Treatments (20 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Polyomavirus and related diseases (11 papers). Karl L. Womer collaborates with scholars based in United States, United Kingdom and South Korea. Karl L. Womer's co-authors include Mohamed H. Sayegh, Bruce Kaplan, Yanfei Huang, Hamid Rabb, John P. Vella, Joren C. Madsen, Titte R. Srinivas, Kazuhiko Yamada, Richard J. Howard and Anil Chandraker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Karl L. Womer

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl L. Womer United States 26 680 647 544 307 176 55 1.6k
Nelson Goes United States 15 846 1.2× 791 1.2× 693 1.3× 334 1.1× 243 1.4× 31 2.0k
Waichi Wong United States 15 816 1.2× 539 0.8× 531 1.0× 109 0.4× 130 0.7× 23 1.4k
D. Phelan United States 26 1.1k 1.6× 1.3k 2.0× 474 0.9× 138 0.4× 152 0.9× 65 1.9k
Lucile E. Wrenshall United States 22 407 0.6× 478 0.7× 367 0.7× 107 0.3× 299 1.7× 53 1.5k
L. Thomas Chin United States 18 691 1.0× 918 1.4× 444 0.8× 147 0.5× 98 0.6× 25 1.7k
Ivy A. Rosales United States 21 482 0.7× 778 1.2× 213 0.4× 109 0.4× 256 1.5× 105 1.6k
Melissa Y. Yeung United States 17 257 0.4× 277 0.4× 876 1.6× 218 0.7× 247 1.4× 38 1.5k
Rachel M. McKenna Canada 21 1.3k 2.0× 1.0k 1.6× 355 0.7× 166 0.5× 241 1.4× 49 2.2k
L. Mjörnstedt Sweden 19 771 1.1× 796 1.2× 136 0.3× 163 0.5× 80 0.5× 79 1.4k
Willem J. Van der Werf United States 18 470 0.7× 1.0k 1.6× 128 0.2× 108 0.4× 97 0.6× 29 1.5k

Countries citing papers authored by Karl L. Womer

Since Specialization
Citations

This map shows the geographic impact of Karl L. Womer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl L. Womer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl L. Womer more than expected).

Fields of papers citing papers by Karl L. Womer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl L. Womer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl L. Womer. The network helps show where Karl L. Womer may publish in the future.

Co-authorship network of co-authors of Karl L. Womer

This figure shows the co-authorship network connecting the top 25 collaborators of Karl L. Womer. A scholar is included among the top collaborators of Karl L. Womer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl L. Womer. Karl L. Womer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Womer, Karl L., et al.. (2018). Not all inflammation in a renal allograft is rejection. Clinical Case Reports. 6(11). 2285–2286. 4 indexed citations
2.
Casey, Michael J., Tezcan Ozrazgat‐Baslanti, Shahab Bozorgmehri, et al.. (2018). A Pilot Study of Immunosuppression Resumption Following BK Viremia Resolution. Transplantation. 102(Supplement 7). S565–S565. 1 indexed citations
3.
Casey, Michael J., et al.. (2016). Association of Baseline Viral Serology and Sirolimus Regimens With Kidney Transplant Outcomes. Transplantation. 101(2). 377–386. 12 indexed citations
4.
Casey, Michael J., et al.. (2016). Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients. American Journal of Transplantation. 16(11). 3202–3211. 25 indexed citations
5.
Casey, Michael J., Xuerong Wen, Ivan Zendejas, et al.. (2015). Survival With Dialysis Versus Kidney Transplantation in Adult Hemolytic Uremic Syndrome Patients. Transplantation. 99(12). 2608–2616. 7 indexed citations
6.
Xiao, Zuoxiang, Andrew Marshall, Hiroaki Kimura, et al.. (2011). Inhibition of Fas Ligand in NOD Mice Unmasks a Protective Role for IL-10 against Insulitis Development. American Journal Of Pathology. 179(2). 725–732. 24 indexed citations
7.
Alachkar, Nada, Richard Ugarte, Edmund Huang, et al.. (2010). Stem Cell Factor, Interleukin-16, and Interleukin-2 Receptor Alpha are Predictive Biomarkers for Delayed and Slow Graft Function. Transplantation Proceedings. 42(9). 3399–3405. 6 indexed citations
8.
Huang, Yanfei, Ping Chen, Gang Jee Ko, et al.. (2010). Kidney-Derived Mesenchymal Stromal Cells Modulate Dendritic Cell Function to Suppress Alloimmune Responses and Delay Allograft Rejection. Transplantation. 90(12). 1307–1311. 25 indexed citations
9.
Ko, Gang Jee, et al.. (2010). Immunologic research in kidney ischemia/reperfusion injury at Johns Hopkins University. Immunologic Research. 47(1-3). 78–85. 8 indexed citations
10.
Huang, Yanfei, Matthew Parker, Chang‐Qing Xia, et al.. (2009). Rabbit Polyclonal Mouse Antithymocyte Globulin Administration Alters Dendritic Cell Profile and Function in NOD Mice to Suppress Diabetogenic Responses. The Journal of Immunology. 182(8). 4608–4615. 14 indexed citations
11.
Womer, Karl L. & Bruce Kaplan. (2009). Recent Developments in Kidney Transplantation-A Critical Assessment. American Journal of Transplantation. 9(6). 1265–1271. 55 indexed citations
12.
Huang, Yanfei, Peter V. Johnston, Borui Zhang, et al.. (2009). Kidney-Derived Stromal Cells Modulate Dendritic and T Cell Responses. Journal of the American Society of Nephrology. 20(4). 831–841. 30 indexed citations
13.
Huang, Yanfei, Hamid Rabb, & Karl L. Womer. (2007). Ischemia–reperfusion and immediate T cell responses. Cellular Immunology. 248(1). 4–11. 118 indexed citations
14.
Womer, Karl L.. (2007). Transplantation Tolerance. PubMed. 16(4). 431–442. 2 indexed citations
15.
Womer, Karl L., Giselle Guerra, Yanfei Huang, et al.. (2007). Immunosuppression reduction for BK virus nephropathy: a case for caution. Transplant Infectious Disease. 9(3). 244–248. 15 indexed citations
16.
Womer, Karl L., et al.. (2006). Why Hasn't Eliminating Acute Rejection Improved Graft Survival?. Annual Review of Medicine. 58(1). 369–385. 70 indexed citations
17.
Womer, Karl L., Ruihua Peng, Pamela R. Patton, et al.. (2005). The effects of renal transplantation on circulating precursor dendritic cells. Transplantation Proceedings. 37(1). 3–6. 4 indexed citations
18.
Womer, Karl L., et al.. (2001). The role of indirect recognition of donor MHC class II peptides in cardiac transplantation in miniature swine. The Journal of Heart and Lung Transplantation. 20(2). 172–172. 5 indexed citations
19.
Reznik, Scott I., Andrés Jaramillo, Krovvidi S. R. SivaSai, et al.. (2001). Indirect Allorecognition of Mismatched Donor HLA Class II Peptides in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome. American Journal of Transplantation. 1(3). 228–235. 68 indexed citations
20.
Womer, Karl L., et al.. (2001). Tolerance and chronic rejection. Philosophical Transactions of the Royal Society B Biological Sciences. 356(1409). 727–738. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nelson Goes Breakdown of academic impact, for papers by Waichi Wong Breakdown of academic impact, for papers by D. Phelan Breakdown of academic impact, for papers by Lucile E. Wrenshall Breakdown of academic impact, for papers by L. Thomas Chin Breakdown of academic impact, for papers by Ivy A. Rosales Breakdown of academic impact, for papers by Melissa Y. Yeung Breakdown of academic impact, for papers by Rachel M. McKenna Breakdown of academic impact, for papers by L. Mjörnstedt Breakdown of academic impact, for papers by Willem J. Van der Werf
Rankless by CCL
2026